RIVENDELL GROUP LLP for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to drug pricing, including International Pricing Index proposals; issues related to Medicare and Medicaid coverage and reimbursement; drug pricing, importation and manufacturing; 340B.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Health Issues HCR
Issues related to drug pricing, including International Pricing Index proposals; issues related to Medicare and Medicaid coverage and reimbursement; CARES Act; legislation related to preparedness and response to coronavirus; Strategic National Stockpile funding and oversight; 340B drug discount program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LAWRENCE BERZOK | LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch |
| NICK KOLOVOS | LA and Counsel, Rep. Anna Eshoo |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.